泰兰尼克龙®对安德روج因依赖性前列腺癌细胞的抗癌作用
Yalçın Erzurumlu1, Hatice Kübra Doğan2, Deniz Çataklı3
1Süleyman Demirel University, Faculty of Pharmacy, Department of Biochemistry, Isparta, Türkiye.
Turkish journal of pharmaceutical sciences
|January 23, 2024
概括
蜘蛛毒提取物Theranekron通过降低活力和抑制关键蛋白质,对前列腺癌 (PCa) 细胞表现出强大的抗癌作用. 这种天然化合物可能为PCa提供新的治疗策略,并克服治疗耐药性.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 前列腺癌 (PCa) 对男性来说是一个重大的全球健康挑战.
- 对现有治疗方法的获得性耐药性限制了PCa的治疗成功.
- 新的治疗策略对于管理PCa和克服抗药性至关重要.
研究的目的:
- 研究Tarantula cubensis的提取物Theranekron的抗增殖活性,对抗依赖于雄激素的PCa细胞.
- 为了检查Theranekron对雄激素信号传递和细胞周期蛋白质的生化作用.
- 评估Theranekron作为PCa的替代或辅助治疗剂的潜力.
主要方法:
- 在体外研究中使用了依赖于雄激素的人类PCa细胞系 (LNCaP,VCaP,22Rv1).
- 通过基于WST-1的测定来评估细胞活力.
- 通过免疫阻塞检查检查了雄激素受体 (AR),环林A2,环林B1和环林E1的蛋白质水平.
- 评估了使用柔软阿加尔试验对3D瘤形成的抗恶性效应.
主要成果:
- 烯显著降低了PCa细胞的活力,以剂量依赖的方式.
- 泰拉尼克隆显著降低了AR,环林A2,环林B1和环林E1.1的蛋白质水平.
- 泰兰尼克龙强烈抑制了LNCaP,22Rv1和VCaP细胞的3D瘤形成.
结论:
- 泰兰尼克龙显示出强大的治疗疗效,对抗依赖雄激素的前列腺癌细胞.
- 泰兰尼克龙可以作为一种有价值的药物,用于预防对化疗药物的耐药性.
- 这些发现支持Theranekron在PCa新型抗癌治疗策略中的潜力.
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:38Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
02:15Replicative Cell Senescence
3.6K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.6K
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
02:34Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K